OpenURL Connection Search

Select item for more details and to access through your institution.

Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.
Published in:
2008
By:
- Kim, Peter S.;
- Armstrong, Todd D.;
- Hong Song;
- Wolpoe, Matthew E.;
- Weiss, Vivian;
- Manning, Elizabeth A.;
- Lan Qing Huang;
- Murata, Satoshi;
- Sgouros, George;
- Emens, Leisha A.;
- Reilly, R. Todd;
- Jaffee1,2,3,5, Elizabeth M.;
- Song, Hong;
- Huang, Lan Qing;
- Jaffee, Elizabeth M
Publication type:
journal article
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10898-z
By:
- Huang, Cheng;
- Zhu, Xiao-Dong;
- Shen, Ying-Hao;
- Xu, Bin;
- Wu, Dong;
- Ji, Yuan;
- Chen, Ling-Li;
- Song, Tian-Qiang;
- Zhang, Wei;
- Zeng, Zhi-Ming;
- Huang, Hua-Sheng;
- Wang, Kui;
- Huang, Lan-Qing;
- Chen, Yong-Jun;
- Yang, Yu-Chen;
- Zhou, Le-Du;
- Long, Guo;
- Zhao, Hai-Tao;
- Wang, Yun-Chao;
- Ge, Ning-Ling
Publication type:
Article
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 262, doi. 10.1159/000528034
By:
- Xu, Bin;
- Dong, San-Yuan;
- Bai, Xue-Li;
- Song, Tian-Qiang;
- Zhang, Bo-Heng;
- Zhou, Le-Du;
- Chen, Yong-Jun;
- Zeng, Zhi-Ming;
- Wang, Kui;
- Zhao, Hai-Tao;
- Lu, Na;
- Zhang, Wei;
- Li, Xu-Bin;
- Zheng, Su-Su;
- Long, Guo;
- Yang, Yu-Chen;
- Huang, Hua-Sheng;
- Huang, Lan-Qing;
- Wang, Yun-Chao;
- Liang, Fei
Publication type:
Article

Found: 3

Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.